Perspective Therapeutics, Inc. — Director's Dealing 2011

Mar 1, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2011-02-23

Reporting Person: Babcock Dwight William (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-23	Common Stock	P	6612	$1.29	Acquired	134773	Direct
2011-02-28	Common Stock	P	16900	$1.3	Acquired	151673	Direct